TheBlock
Circle has acquired IBM's blockchain patent portfolio, more than 680 patent families and nearly 1,000 issued patents, making it the largest blockchain patent holder in the U.S. The portfolio covers foundational blockchain technology alongside banking, financial services, insurance, and supply chain verification.
Why it matters
The IP directly supports USDC, the Circle Payments Network, and Arc, Circle's enterprise-focused blockchain. Owning the underlying patents rather than licensing them gives Circle defensive moat and offensive leverage as it pushes deeper into bank-grade settlement rails and tokenized funds. For institutional counterparts evaluating USDC rails, patent ownership is one more box to check against open-source or consortium alternatives.
Market impact
For IBM, the divestiture continues a multi-year rotation away from in-house blockchain commercialization after the Hyperledger and TradeLens wind-downs. For Circle, it lands ahead of continued USDC distribution expansion and the Arc mainnet rollout, where defensible IP around settlement, identity, and supply-chain provenance has been a recurring enterprise procurement question.
Frequently asked questions
-
How many patents did Circle acquire from IBM?
Circle acquired more than 680 patent families and nearly 1,000 issued patents from IBM's blockchain portfolio, making it the largest blockchain patent holder in the U.S.
-
What areas do the patents cover?
The portfolio covers foundational blockchain technology alongside banking, financial services, insurance, and supply chain verification.
-
Which Circle products benefit from the acquired IP?
The patents directly support USDC, the Circle Payments Network, and Arc, Circle's enterprise-focused blockchain.
-
Why does this matter for institutional adoption of USDC?
Owning the underlying patents rather than licensing them gives Circle additional defensive and offensive leverage as it courts bank-grade settlement and tokenized-fund use cases.
-
What does the sale mean for IBM?
The divestiture continues IBM's multi-year rotation away from in-house blockchain commercialization following earlier wind-downs like Hyperledger and TradeLens.
Crypto News
CoinDesk
CoinTelegraph
CryptoSlate
Crypto Rank News